142 related articles for article (PubMed ID: 24053423)
1. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
Dileep KV; Remya C; Tintu I; Sadasivan C
J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new ibuprofen derivatives with their in silico and in vitro cyclooxygenase-2 inhibitions.
Gundogdu-Hizliates C; Alyuruk H; Gocmenturk M; Ergun Y; Cavas L
Bioorg Chem; 2014 Feb; 52():8-15. PubMed ID: 24270352
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided, rational design of a potent and selective small peptide inhibitor of cyclooxygenase 2 (COX2).
Rajakrishnan V; Manoj VR; Subba Rao G
J Biomol Struct Dyn; 2008 Apr; 25(5):535-42. PubMed ID: 18282008
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
6. Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.
Estevão MS; Carvalho LC; Freitas M; Gomes A; Viegas A; Manso J; Erhardt S; Fernandes E; Cabrita EJ; Marques MM
Eur J Med Chem; 2012 Aug; 54():823-33. PubMed ID: 22796043
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
[TBL] [Abstract][Full Text] [Related]
8. Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development.
Singh S; Pandey VP; Naaz H; Singh P; Dwivedi UN
Comput Biol Med; 2013 Jul; 43(6):744-50. PubMed ID: 23668350
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of loxoprofen derivatives.
Yamakawa N; Suemasu S; Matoyama M; Tanaka K; Katsu T; Miyata K; Okamoto Y; Otsuka M; Mizushima T
Bioorg Med Chem; 2011 Jun; 19(11):3299-311. PubMed ID: 21570308
[TBL] [Abstract][Full Text] [Related]
10. Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies.
Abuo-Rahma Gel-D; Abdel-Aziz M; Farag NA; Kaoud TS
Eur J Med Chem; 2014 Aug; 83():398-408. PubMed ID: 24983538
[TBL] [Abstract][Full Text] [Related]
11. Cycloxygenase-2 (COX-2)--a potential target for screening of small molecules as radiation countermeasure agents: an in silico study.
Joshi J; Barik TK; Shrivastava N; Dimri M; Ghosh S; Mandal RS; Ramachandran S; Kumar IP
Curr Comput Aided Drug Des; 2013 Mar; 9(1):35-45. PubMed ID: 23905928
[TBL] [Abstract][Full Text] [Related]
12. Trimethyl-4-oxo-4,5,6,7-tetrahydroindazole-1-acetic acid: a new lead compound with selective COX-2 inhibitory activity.
Abdel-Rahman HM; Ozadali K
Arch Pharm (Weinheim); 2012 Nov; 345(11):878-83. PubMed ID: 22907715
[TBL] [Abstract][Full Text] [Related]
13. Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug.
Shaveta ; Singh A; Kaur M; Sharma S; Bhatti R; Singh P
Eur J Med Chem; 2014 Apr; 77():185-92. PubMed ID: 24631898
[TBL] [Abstract][Full Text] [Related]
14. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors.
Consalvi S; Alfonso S; Di Capua A; Poce G; Pirolli A; Sabatino M; Ragno R; Anzini M; Sartini S; La Motta C; Di Cesare Mannelli L; Ghelardini C; Biava M
Bioorg Med Chem; 2015 Feb; 23(4):810-20. PubMed ID: 25596758
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
17. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent.
Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S
Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617
[TBL] [Abstract][Full Text] [Related]
18. Diaryl-Substituted (Dihydro)pyrrolo[3,2,1-hi]indoles, a Class of Potent COX-2 Inhibitors with Tricyclic Core Structure.
Laube M; Gassner C; Sharma SK; Günther R; Pigorsch A; König J; Köckerling M; Wuest F; Pietzsch J; Kniess T
J Org Chem; 2015 Jun; 80(11):5611-24. PubMed ID: 25909690
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.
Unsal-Tan O; Ozadali K; Piskin K; Balkan A
Eur J Med Chem; 2012 Nov; 57():59-64. PubMed ID: 23047224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
